India, Feb. 11 -- PE firm JV Ventures' life sciences-focussed arm Innovation Acceleration Platform (IXP) has launched its first fund to invest in early stage startups.

The fund, IXP Lifesciences Catalyst Fund, has a target corpus of INR 200 Cr, with a greenshoe option of INR 100 Cr.

It aims to invest in B2B companies at pre-seed to Series A stages, and build a portfolio of 20-25 startups focussed on both products and services in the life sciences sector. The key investment areas will include pharmaceuticals, biotechnology, medical technology, speciality chemicals, agrotechnology, and nutraceuticals.

". The sector is nuanced and requires investors with scientific expertise, industry knowledge, and operational experience to help biotech ...